EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Change of Personnel Kuros appoints Philippe Saudan as Chief Development Officer 10.08.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. 490963 10.08.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Research Update Kuros Biosciences AG: valuationLAB Initiates Research Coverage on Kuros 28.06.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 474863 28.06.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Miscellaneous First Trading Day of New Kuros Share after Reverse Split 23.06.2016 / 18:31 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 473985 23.06.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): AGM/EGM Kuros Bioscience's Shareholders Approve All Resolutions 16.06.2016 / 14:38 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 472175 16.06.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): AGM/EGM Kuros Biosciences Invites to the Annual Shareholders' Meeting 2016 26.05.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 466703 26.05.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Final Results Kuros Biosciences Reports Financial Results for 2015 26.04.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 457559 26.04.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Miscellaneous Kuros receives milestone payment from Checkmate 20.04.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 455711 20.04.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Change of Personnel Kuros Biosciences Ltd. appoints Chief Medical Officer 08.03.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 443197 08.03.2016 ...
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Merger Kuros Biosurgery Holding Ltd. closes merger with Cytos Biotechnology Ltd. which is renamed Kuros Biosciences Ltd 20.01.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this ...